Decrease in circulating endothelial progenitor cells in treated glioma patients

Elena Corsini, Emilio Ciusani, Paola Gaviani, Antonio Silvani, Alessandra Canazza, Gaetano Bernardi, Chiara Calatozzolo, Francesco Di Meco, Andrea Salmaggi

Research output: Contribution to journalArticle

Abstract

High-grade gliomas are highly vascularized tumors, in which the amount of new blood vessels is closely related with the degree of malignancy. The role of endothelial progenitor cells (EPCs) in the neoangiogenesis of gliomas and the effects of post-surgical therapies (i.e., radiotherapy (RT) and chemotherapy) have not yet been fully elucidated. The aim of the present study was to evaluate the effect of surgery and post-surgical treatment on the levels of circulating EPCs in glioma patients and their correlation with vascular endothelial growth factor (VEGF). In this study, we assessed by flow cytometry the number of EPCs in the peripheral blood of 78 high-grade glioma patients (both untreated and treated with RT and chemotherapy) and 34 age- and sex-matched healthy controls. EPCs were markedly decreased in all treated glioma patients as compared to untreated ones. VEGF levels were significantly higher in patients as compared to controls, and surgery, but not chemotherapy, significantly decreased VEGF concentrations. We found no relationship between VEGF plasma levels and EPCs. In conclusion, the reliability of EPCs as a biomarker for monitoring angiogenesis in glioma patients needs further studies of correlations of this parameter with other markers of tumor-related vasculature.

Original languageEnglish
Pages (from-to)123-129
Number of pages7
JournalJournal of Neuro-Oncology
Volume108
Issue number1
DOIs
Publication statusPublished - May 2012

Fingerprint

Glioma
Vascular Endothelial Growth Factor A
Drug Therapy
Radiotherapy
Tumor Biomarkers
Blood Vessels
Endothelial Progenitor Cells
Neoplasms
Flow Cytometry
Biomarkers
Therapeutics

Keywords

  • Angiogenesis
  • Chemotherapy
  • Circulating endothelial progenitor cells
  • Glioma
  • Radiotherapy
  • Surgery
  • VEGF

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Decrease in circulating endothelial progenitor cells in treated glioma patients. / Corsini, Elena; Ciusani, Emilio; Gaviani, Paola; Silvani, Antonio; Canazza, Alessandra; Bernardi, Gaetano; Calatozzolo, Chiara; Meco, Francesco Di; Salmaggi, Andrea.

In: Journal of Neuro-Oncology, Vol. 108, No. 1, 05.2012, p. 123-129.

Research output: Contribution to journalArticle

@article{6eeef11199a04c6581f3f2bc3615ade5,
title = "Decrease in circulating endothelial progenitor cells in treated glioma patients",
abstract = "High-grade gliomas are highly vascularized tumors, in which the amount of new blood vessels is closely related with the degree of malignancy. The role of endothelial progenitor cells (EPCs) in the neoangiogenesis of gliomas and the effects of post-surgical therapies (i.e., radiotherapy (RT) and chemotherapy) have not yet been fully elucidated. The aim of the present study was to evaluate the effect of surgery and post-surgical treatment on the levels of circulating EPCs in glioma patients and their correlation with vascular endothelial growth factor (VEGF). In this study, we assessed by flow cytometry the number of EPCs in the peripheral blood of 78 high-grade glioma patients (both untreated and treated with RT and chemotherapy) and 34 age- and sex-matched healthy controls. EPCs were markedly decreased in all treated glioma patients as compared to untreated ones. VEGF levels were significantly higher in patients as compared to controls, and surgery, but not chemotherapy, significantly decreased VEGF concentrations. We found no relationship between VEGF plasma levels and EPCs. In conclusion, the reliability of EPCs as a biomarker for monitoring angiogenesis in glioma patients needs further studies of correlations of this parameter with other markers of tumor-related vasculature.",
keywords = "Angiogenesis, Chemotherapy, Circulating endothelial progenitor cells, Glioma, Radiotherapy, Surgery, VEGF",
author = "Elena Corsini and Emilio Ciusani and Paola Gaviani and Antonio Silvani and Alessandra Canazza and Gaetano Bernardi and Chiara Calatozzolo and Meco, {Francesco Di} and Andrea Salmaggi",
year = "2012",
month = "5",
doi = "10.1007/s11060-012-0805-8",
language = "English",
volume = "108",
pages = "123--129",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Decrease in circulating endothelial progenitor cells in treated glioma patients

AU - Corsini, Elena

AU - Ciusani, Emilio

AU - Gaviani, Paola

AU - Silvani, Antonio

AU - Canazza, Alessandra

AU - Bernardi, Gaetano

AU - Calatozzolo, Chiara

AU - Meco, Francesco Di

AU - Salmaggi, Andrea

PY - 2012/5

Y1 - 2012/5

N2 - High-grade gliomas are highly vascularized tumors, in which the amount of new blood vessels is closely related with the degree of malignancy. The role of endothelial progenitor cells (EPCs) in the neoangiogenesis of gliomas and the effects of post-surgical therapies (i.e., radiotherapy (RT) and chemotherapy) have not yet been fully elucidated. The aim of the present study was to evaluate the effect of surgery and post-surgical treatment on the levels of circulating EPCs in glioma patients and their correlation with vascular endothelial growth factor (VEGF). In this study, we assessed by flow cytometry the number of EPCs in the peripheral blood of 78 high-grade glioma patients (both untreated and treated with RT and chemotherapy) and 34 age- and sex-matched healthy controls. EPCs were markedly decreased in all treated glioma patients as compared to untreated ones. VEGF levels were significantly higher in patients as compared to controls, and surgery, but not chemotherapy, significantly decreased VEGF concentrations. We found no relationship between VEGF plasma levels and EPCs. In conclusion, the reliability of EPCs as a biomarker for monitoring angiogenesis in glioma patients needs further studies of correlations of this parameter with other markers of tumor-related vasculature.

AB - High-grade gliomas are highly vascularized tumors, in which the amount of new blood vessels is closely related with the degree of malignancy. The role of endothelial progenitor cells (EPCs) in the neoangiogenesis of gliomas and the effects of post-surgical therapies (i.e., radiotherapy (RT) and chemotherapy) have not yet been fully elucidated. The aim of the present study was to evaluate the effect of surgery and post-surgical treatment on the levels of circulating EPCs in glioma patients and their correlation with vascular endothelial growth factor (VEGF). In this study, we assessed by flow cytometry the number of EPCs in the peripheral blood of 78 high-grade glioma patients (both untreated and treated with RT and chemotherapy) and 34 age- and sex-matched healthy controls. EPCs were markedly decreased in all treated glioma patients as compared to untreated ones. VEGF levels were significantly higher in patients as compared to controls, and surgery, but not chemotherapy, significantly decreased VEGF concentrations. We found no relationship between VEGF plasma levels and EPCs. In conclusion, the reliability of EPCs as a biomarker for monitoring angiogenesis in glioma patients needs further studies of correlations of this parameter with other markers of tumor-related vasculature.

KW - Angiogenesis

KW - Chemotherapy

KW - Circulating endothelial progenitor cells

KW - Glioma

KW - Radiotherapy

KW - Surgery

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84860286026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860286026&partnerID=8YFLogxK

U2 - 10.1007/s11060-012-0805-8

DO - 10.1007/s11060-012-0805-8

M3 - Article

C2 - 22350374

AN - SCOPUS:84860286026

VL - 108

SP - 123

EP - 129

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -